Trials / Completed
CompletedNCT00265031
HD12 for Advanced Stages
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- University of Cologne · Academic / Other
- Sex
- All
- Age
- 16 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to test (1) whether the BEACOPP dosage can be reduced to baseline in the last 4 cycles without loss of effectiveness, and (2) whether consolidating irradiation is necessary following effective chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cyclophosphamide | |
| DRUG | Adriamycin | |
| DRUG | Etoposide | |
| DRUG | Procarbazine | |
| DRUG | Prednisone | |
| DRUG | Vincristine | |
| DRUG | Bleomycin | |
| PROCEDURE | radiation therapy |
Timeline
- Start date
- 1999-01-01
- First posted
- 2005-12-13
- Last updated
- 2012-06-25
Source: ClinicalTrials.gov record NCT00265031. Inclusion in this directory is not an endorsement.